Gene Therapy Clinical Trial for Krabbe Disease is Recruiting Patients episode artwork

EPISODE · Jul 7, 2021 · 1 MIN

Gene Therapy Clinical Trial for Krabbe Disease is Recruiting Patients

from Rare Disease Discussions · host CheckRare Editors

Tim Miller, PhD, CEO, President, and Co-Founder of Forge Biologics, discusses the phase 1/2 RESKUE study which will evaluate FBX-101 for the treatment of Krabbe disease. This clinical trial is currently recruiting.Rare Discussions is produced by CheckRare, the leading multimedia platform dedicated to advancing education, awareness, and innovation across the rare disease community.Explore additional physician interviews, podcasts, CME activities, and rare disease resources at CheckRare.com.Subscribe to the CheckRare Podcast Network for expert conversations, weekly news, accredited education, and the latest advances across the rare disease community.Part of the CheckRare Podcast Network: Trusted conversations, news, education, and expert insights across the rare disease community.

Episode metadata supplied by the publisher feed · Published Jul 7, 2021

Embed this episode

NOW PLAYING

Gene Therapy Clinical Trial for Krabbe Disease is Recruiting Patients

0:00 1:46

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Rare Disease Discussions?

This episode is 1 minute long.

When was this Rare Disease Discussions episode published?

This episode was published on July 7, 2021.

Can I download this Rare Disease Discussions episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!